Clasp Therapeutics
Pioneering precise immuno-oncology with next-gen T cell engagers targeting specific tumor mutations
42 employees · est. 2020
Harpoon Therapeutics
SPEARHEADING IMMUNOTHERAPIES
33 employees · est. 2015 · South San Francisco, United...
Harpoon Therapeutics is the older company (2020 vs 2015).
Side-by-Side Comparison
| Metric | Clasp Therapeutics | Harpoon Therapeutics |
|---|---|---|
| Founded | ||
| Founded | 2020 | 2015 older |
| Headquarters | ||
| Headquarters | Not tracked yet | South San Francisco, United States |
| Employees | ||
| Employees | 42 | 33 |
| Industry | ||
| Industry | Not tracked yet | Biotechnology, Health Care, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Series A | Post Ipo Equity |
| Total Funding | ||
| Total Funding | $150.00M | $255.00M |
| Funding Rounds | ||
| Funding Rounds | 1 | 5 |
| Services | ||
| Services | Discovery and development of off-the-shelf precision immunotherapies, Development of T cell engager molecules, Clinical trial execution for novel cancer treatments | R&D in various therapeutic areas, Clinical trials, Patient assistance programs, Business development and licensing, Merck Medical Outreach Program |
| Target Customers | ||
| Target Customers | Cancer Patients, Oncologists, Biopharmaceutical Companies, Healthcare Providers | Patients, Healthcare professionals, Investors, Pharmaceutical distributors, Healthcare providers |
| Taxonomy | ||
| Taxonomy | Immuno-oncology, T Cell Engagers, Tumor-specific Mutations, Personalized Therapeutics, Oncogenic Driver Mutations, Precision Medicine, Cancer Treatment, Biotech Startup, Next-generation Therapies, Academic Research Collaboration, Life Sciences Investment, Advanced Therapeutics, Immune System Engagement, Hard-to-treat Cancers, Genome-targeted Therapy | Immunotherapy, Oncology, T Cell Engagers, Tri-specific T Cell Activating Construct (TriTAC), Solid Tumors, Hematologic Malignancies, ProTriTAC, Prodrug Concept, Extended Release TriTAC-XR, Cancer Treatment, Immune System Therapy, Clinical-stage Company, Novel Drug Development, Proprietary Technology |
| Website | ||
| Website | clasptx.com | harpoontx.com |
About Clasp Therapeutics
Clasp Therapeutics is positioning itself at the forefront of the immuno-oncology field, as illustrated by its slogan: "Pioneering precise immuno-oncology with next-gen T cell engagers targeting specific tumor mutations." Focused on harnessing next-generation T cell engagers (TCEs), the company aims...
About Harpoon Therapeutics
Harpoon Therapeutics, established in 2015, is a notable player in the Biotechnology and Health Care sectors, based in the United States. The company operates under the slogan SPEARHEADING IMMUNOTHERAPIES and is primarily focused on developing innovative therapies to harness the immune system for tre...
We will tell you when either one moves
BounceWatch watches Clasp Therapeutics and Harpoon Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Clasp Therapeutics and Harpoon Therapeutics — by email.
Frequently Asked Questions
Compare Clasp Therapeutics with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Clasp Therapeutics on 9 Jun 2026, and Harpoon Therapeutics on 11 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
